View drug registration information details.
| Items | Registration information |
|---|
| ID | 2537 |
|---|
| No | 2537 |
|---|
| Brand Name | OLAVEX 5 MD |
|---|
| Ingredients | Olanzapine USP 5 mg |
|---|
| Dosage Form | Tablets |
|---|
| Primary Packaging | Alu-Alu Blister |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | for the treatment of schizophrenia, for the treatment of moderate to severe
manic episode, In patients whose manic episode has responded to OLAVEX
treatment, OLAVEX is indicated for the prevention of recurrence
in patients with bipolar disorder |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | Yellow colour round shape flate uncoated tablet with Breakline on one side. |
|---|
| Note | |
|---|
| License Owner | VE PRODUCTS (LAO) CO.,LTD |
|---|
| Manufacturer | WEST-COAST PHARMACEUTICAL WORKS LTD |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 12 I 5837/24 |
|---|
| FDD Registration Date | 30-DEC-2024 |
|---|
| Expiry Date | 29-DEC-2029 |
|---|
Back to drug list
|
